Skip to main content

Table 1 Baseline characteristics of participants included in the study

From: NK cell frequencies, function and correlates to vaccine outcome in BNT162b2 mRNA anti-SARS-CoV-2 vaccinated healthy and immunocompromised individuals

  Healthy Individudals (n = 41) Primary Immuno-deficiencies (n = 16) People Living With HIV (n = 48) Solid Organ Transplantation (n = 34*)
Sex, n (%)
 Men 19 (46%) 8 (50%) 26 (54%) 18 (53%)
 Women 22 (54%) 8 (50%) 22 46%) 16 (47%)
Age < 65 years, n (%) 28 (68%) 13 (81%) 37 (77%) 24 (71%)
Ongoing immune-suppression, n (%)
 Corticosteroids 0 0 0 32 (94%)
 Other immune-suppressive agents 0 1 (6%) 0 34 (100%)
Subgroups (n) 1. 18–39 years (n = 16)
2. 40–59 years (n = 12)
3. > 60 years (n = 13)
1. CVID (n = 3)
2. Low number or defect
T-cell function (n = 8)
3. Monogenic diseases (n = 2)
4. Other with expected
normal response (n = 3)
1. Latest CD4 T cell count ≤ 300 cells/μl (n = 16)
2. Latest CD4 T cell count > 300 cells/μl (n = 32)
Time after transplantation:
1. ≤ 6 mo (n = 19)
with/without MMF
2. > 6 mo with MMF
(n = 6)
3. > 6 mo without
MMF (n = 9)
  1. n number, HIV human immunodeficiency virus, CVID common variable immunodeficiency, IgA immunoglobulin A, CD cluster of differentiation, MMF mycophenolate mofetil.
  2. *The different transplants in the SOT group (n = 34) were liver (n = 19), kidney (n = 14) and kidney and pancreas (n = 1)